The impact of multimorbidity on foot health outcomes in podiatry patients with musculoskeletal foot pain: a prospective observational study

Table 5 Group comparisons for FHSQ domains at baseline, 3 and 6 month follow-ups

	FHSQpain, median (IQR)	FHSQfunction, median (IQR)	FHSQfootwear, median (IQR)	FHSQhealth, median (IQR)
Baseline
No condition	41.88 (43.13)	62.5 (40.63)**	41.67 (39.58)	33.75 (38.13)**
Single condition	41.25 (41.25)	65.63 (31.25)**‡‡	37.5 (41.67)	36.25 (44.38)**‡
> 1 conditions	29.38 (48.75)	31.25 (53.13)**††	25.0 (39.58)	25.0 (42.5)**††
3 months
No condition	60.63 (39.69)	84.38 (28.13)**	29.17 (31.25)	42.5 (53.75)*
Single condition	47.5 (46.25)	87.5 (31.25)**‡‡	41.67 (58.33)	60.0 (35.0)*
> 1 conditions	35.0 (43.13)	46.88 (64.06)**††	25.0 (54.17)	25.0 (60.0)*†
6 months
No condition	69.38 (26.09)*	90.63 (21.88)**	37.5 (52.08)*	60.0 (66.25)*
Single condition	44.69 (48.91)*	87.5 (31.25)**‡‡	41.67 (50.0)* ‡‡	42.5 (60.0)*
> 1 conditions	35.63 (48.91)*††	50.0 (59.38)**††	25.0 (45.83)*	25.0 (51.25)*†

Kruskall-Wallis tests significant at **p < 0.01 and *p < 0.05
Post-hoc Mann-Whitney tests significant at ‡‡p < 0.01 and ‡p < 0.05 for Single Condition versus > 1 conditions group comparison
Post-hoc Mann-Whitney tests significant at ††p < 0.01 and †p < 0.05 for No conditions versus > 1 conditions comparison
FHSQ Foot health status questionnaire, IQR Interquartile range

ISSN: 1757-1146